Edward Levine to Antineoplastic Agents, Hormonal
This is a "connection" page, showing publications Edward Levine has written about Antineoplastic Agents, Hormonal.
Connection Strength
0.164
-
Postlewait LM, Ethun CG, Tran TB, Prescott JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Staley CA, Poultsides GA, Maithel SK. Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group. J Am Coll Surg. 2016 Apr; 222(4):480-90.
Score: 0.132
-
Jackson LC, Camacho F, Levine EA, Anderson RT, Stewart JH. Patterns of care analysis among women with ductal carcinoma in situ in North Carolina. Am J Surg. 2008 Feb; 195(2):164-9.
Score: 0.019
-
Shah S, Doyle K, Lange EM, Shen P, Pennell T, Ferree C, Levine EA, Perrier ND. Breast cancer recurrences in elderly patients after lumpectomy. Am Surg. 2002 Aug; 68(8):735-9.
Score: 0.013